Nyxoah SA EPS - Earnings per Share 2021-2024 | NYXH
Nyxoah SA eps - earnings per share from 2021 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Nyxoah SA Annual EPS | |
|---|---|
| 2023 | $-1.67 |
| 2022 | $-1.27 |
| 2021 | $-1.37 |
| 2020 | $-0.77 |
| Nyxoah SA Quarterly EPS | |
|---|---|
| 2024-09-30 | $-0.55 |
| 2024-06-30 | $-0.46 |
| 2024-03-31 | $-0.45 |
| 2023-12-31 | $-0.40 |
| 2023-09-30 | $-0.29 |
| 2023-06-30 | $-0.49 |
| 2023-03-31 | $-0.49 |
| 2022-12-31 | $-0.53 |
| 2022-09-30 | $-0.24 |
| 2022-06-30 | $-0.21 |
| 2022-03-31 | $-0.29 |
| 2021-12-31 | $0.00 |
| 2021-06-30 | $0.00 |
| 2021-03-31 | $-0.31 |
| 2020-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||